KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molina Healthcare (MOH) Cash & Equivalents (2016 - 2025)

Molina Healthcare's Cash & Equivalents history spans 16 years, with the latest figure at $4.2 billion for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 10.8% year-over-year to $4.2 billion; the TTM value through Sep 2025 reached $4.2 billion, down 10.8%, while the annual FY2024 figure was $4.7 billion, 3.84% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $4.2 billion at Molina Healthcare, down from $4.5 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $5.6 billion in Q3 2023 and bottomed at $4.0 billion in Q4 2022.
  • The 5-year median for Cash & Equivalents is $4.5 billion (2024), against an average of $4.6 billion.
  • The largest annual shift saw Cash & Equivalents skyrocketed 87.36% in 2021 before it fell 14.97% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $4.4 billion in 2021, then fell by 9.73% to $4.0 billion in 2022, then increased by 21.02% to $4.8 billion in 2023, then decreased by 3.84% to $4.7 billion in 2024, then dropped by 9.46% to $4.2 billion in 2025.
  • Per Business Quant, the three most recent readings for MOH's Cash & Equivalents are $4.2 billion (Q3 2025), $4.5 billion (Q2 2025), and $4.9 billion (Q1 2025).